{"id":379803,"date":"2020-11-12T09:03:33","date_gmt":"2020-11-12T14:03:33","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=379803"},"modified":"2020-11-12T09:03:33","modified_gmt":"2020-11-12T14:03:33","slug":"agenus-and-dr-steven-oday-to-participate-in-panels-at-the-virtual-sitc-2020-immuno-oncology-event-hosted-by-b-riley","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/agenus-and-dr-steven-oday-to-participate-in-panels-at-the-virtual-sitc-2020-immuno-oncology-event-hosted-by-b-riley\/","title":{"rendered":"Agenus and Dr. Steven O\u2019Day to Participate in Panels at the Virtual SITC 2020 Immuno-Oncology Event Hosted by B. Riley"},"content":{"rendered":"
\n

LEXINGTON, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) — Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced that Dr. Steven O\u2019Day, Executive Director of the John Wayne Cancer Institute, Dr. Jennifer Buell, President and COO of Agenus, and Patrick Jordan, COO of AgenTus Therapeutics, will participate in panel discussions at the Virtual SITC 2020 Immuno-Oncology Event hosted by B. Riley.<\/p>\n

\n Date: <\/strong>Thursday, November 12, 2020<\/p>\n

\n Panel #2: Next-Gen Checkpoint Inhibitors (CPI) and Co-Stimulatory Agonists Finally Ready for Prime Time<\/strong>\n <\/p>\n

\n Time: <\/strong>1:00 PM \u2013 2:00 PM ET
Conference ID: <\/strong>311564<\/p>\n

\n Agenus Inc.
<\/strong>Steven O\u2019Day, MD \u2013 Executive Director of the John Wayne Cancer Institute
Jennifer Buell, PhD \u2013 President & COO
Dhan Chand, PhD \u2013 Scientific Director Head of Drug Discovery<\/p>\n

\n Compass Therapeutics
<\/strong>Thomas J. Schuetz, MD, PhD \u2013 Co-Founder & CEO<\/p>\n

\n F-Star Therapeutics
<\/strong>Eliot Forster, PhD\u00a0\u2013 President & CEO
Louis Kayitalire, MD \u2013 CMO<\/p>\n

\n TRIGR Therapeutics
<\/strong>Miranda Toledano \u2013 COO & CFO<\/p>\n

\n Panel #3:<\/strong>
\n Cell Therapy 2.0: Transforming Immune Cells to Mainstream Cancer Treatments <\/strong>\n <\/p>\n

\n Time: <\/strong>2:00 PM \u2013 3:00 PM ET
Conference ID: <\/strong>650564<\/p>\n

\n Agenus Inc.<\/strong>
\n and AgenTus Therapeutics
<\/strong>Jennifer Buell, PhD \u2013 President & COO (Agenus)
Patrick Jordan\u00a0\u2013 COO (AgenTus)<\/p>\n

\n Adicet<\/strong>
\n Bio
<\/strong>Chen Schor \u2013 President & CEO
Stewart Abbott, PhD \u2013 COO & CSO<\/p>\n

\n Mustan<\/strong>
\n g <\/strong>
\n Bio
<\/strong>Manny Litchman, MD \u2013 President & CEO
Knut Niss, PhD \u2013 CTO<\/p>\n

\n Carisma<\/strong>
\n Therapeutics
<\/strong>Steven Kelly \u2013 President & CEO<\/p>\n

\n Glycostem
<\/strong>Troels Jordansen \u2013 CEO
Jan Spanholtz, PhD\u00a0\u2013 CSO<\/p>\n

Replays will be available after the discussions by dialing 800-332-6854 or 973-528-0005 and entering the corresponding conference ID. They will also be available on the Events & Presentations page of the Agenus website at https:\/\/investor.agenusbio.com\/events-and-presentations<\/a><\/p>\n

\n
\n About AgenTus Therapeutics, Inc.<\/u>
\n <\/strong>
\n
AgenTus Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of breakthrough unmodified and modified allogeneic iNKT cells with engineered receptors, such as T cell receptors (TCRs) and Chimeric Antigen Receptors (CARs), designed to supercharge the human immune system cells to seek and destroy cancer. AgenTus also aims to advance adoptive cell therapy formats which would enable off-the-shelf living drugs. AgenTus has locations in Lexington, MA and Cambridge, UK. For more information, please visit www.agentustherapeutics.com.<\/p>\n

\n
\n About Agenus<\/u>
\n <\/strong>
\n
Agenus is a clinical-stage immuno-oncology company focused on the discovery and development of therapies that engage the body’s immune system to fight cancer. The Company’s vision is to expand the patient populations benefiting from cancer immunotherapy by pursuing combination approaches that leverage a broad repertoire of antibody therapeutics, adoptive cell therapies (through its AgenTus Therapeutics subsidiary), and proprietary cancer vaccine platforms. The Company is equipped with a suite of antibody discovery platforms and a state-of-the-art GMP manufacturing facility with the capacity to support clinical programs. Agenus is headquartered in Lexington, MA. For more information, please visit www.agenusbio.com and our Twitter handle @agenus_bio. Information that may be important to investors will be routinely posted on our website and Twitter.<\/p>\n

\n
\n Contact:<\/u>
\n <\/strong>
\n
\n Agenus Inc.\u00a0<\/strong>
\n
Caroline Bafundo
212-994-8209
Caroline.Bafundo@agenusbio.com<\/u><\/a><\/p>\n

\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

LEXINGTON, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) — Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced that Dr. Steven O\u2019Day, Executive Director of the John Wayne Cancer Institute, Dr. Jennifer Buell, President and COO of Agenus, and Patrick Jordan, COO of AgenTus Therapeutics, will participate in panel discussions at the Virtual SITC 2020 Immuno-Oncology Event hosted by B. Riley. Date: Thursday, November 12, 2020 Panel #2: Next-Gen Checkpoint Inhibitors (CPI) and Co-Stimulatory Agonists Finally Ready for Prime Time Time: 1:00 PM \u2013 2:00 PM ETConference ID: 311564 Agenus Inc.Steven O\u2019Day, MD \u2013 Executive Director of the John Wayne … <\/p>\n

Continue reading “Agenus and Dr. Steven O\u2019Day to Participate in Panels at the Virtual SITC 2020 Immuno-Oncology Event Hosted by B. Riley”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-379803","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAgenus and Dr. Steven O\u2019Day to Participate in Panels at the Virtual SITC 2020 Immuno-Oncology Event Hosted by B. Riley - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/agenus-and-dr-steven-oday-to-participate-in-panels-at-the-virtual-sitc-2020-immuno-oncology-event-hosted-by-b-riley\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Agenus and Dr. Steven O\u2019Day to Participate in Panels at the Virtual SITC 2020 Immuno-Oncology Event Hosted by B. Riley - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"LEXINGTON, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) — Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced that Dr. Steven O\u2019Day, Executive Director of the John Wayne Cancer Institute, Dr. Jennifer Buell, President and COO of Agenus, and Patrick Jordan, COO of AgenTus Therapeutics, will participate in panel discussions at the Virtual SITC 2020 Immuno-Oncology Event hosted by B. Riley. Date: Thursday, November 12, 2020 Panel #2: Next-Gen Checkpoint Inhibitors (CPI) and Co-Stimulatory Agonists Finally Ready for Prime Time Time: 1:00 PM \u2013 2:00 PM ETConference ID: 311564 Agenus Inc.Steven O\u2019Day, MD \u2013 Executive Director of the John Wayne … Continue reading "Agenus and Dr. Steven O\u2019Day to Participate in Panels at the Virtual SITC 2020 Immuno-Oncology Event Hosted by B. Riley"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/agenus-and-dr-steven-oday-to-participate-in-panels-at-the-virtual-sitc-2020-immuno-oncology-event-hosted-by-b-riley\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-12T14:03:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NDc0OCMzODIzNjY2IzIwMjAwNDA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agenus-and-dr-steven-oday-to-participate-in-panels-at-the-virtual-sitc-2020-immuno-oncology-event-hosted-by-b-riley\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agenus-and-dr-steven-oday-to-participate-in-panels-at-the-virtual-sitc-2020-immuno-oncology-event-hosted-by-b-riley\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Agenus and Dr. Steven O\u2019Day to Participate in Panels at the Virtual SITC 2020 Immuno-Oncology Event Hosted by B. Riley\",\"datePublished\":\"2020-11-12T14:03:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agenus-and-dr-steven-oday-to-participate-in-panels-at-the-virtual-sitc-2020-immuno-oncology-event-hosted-by-b-riley\\\/\"},\"wordCount\":505,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agenus-and-dr-steven-oday-to-participate-in-panels-at-the-virtual-sitc-2020-immuno-oncology-event-hosted-by-b-riley\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NDc0OCMzODIzNjY2IzIwMjAwNDA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agenus-and-dr-steven-oday-to-participate-in-panels-at-the-virtual-sitc-2020-immuno-oncology-event-hosted-by-b-riley\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agenus-and-dr-steven-oday-to-participate-in-panels-at-the-virtual-sitc-2020-immuno-oncology-event-hosted-by-b-riley\\\/\",\"name\":\"Agenus and Dr. Steven O\u2019Day to Participate in Panels at the Virtual SITC 2020 Immuno-Oncology Event Hosted by B. Riley - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agenus-and-dr-steven-oday-to-participate-in-panels-at-the-virtual-sitc-2020-immuno-oncology-event-hosted-by-b-riley\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agenus-and-dr-steven-oday-to-participate-in-panels-at-the-virtual-sitc-2020-immuno-oncology-event-hosted-by-b-riley\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NDc0OCMzODIzNjY2IzIwMjAwNDA=\",\"datePublished\":\"2020-11-12T14:03:33+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agenus-and-dr-steven-oday-to-participate-in-panels-at-the-virtual-sitc-2020-immuno-oncology-event-hosted-by-b-riley\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agenus-and-dr-steven-oday-to-participate-in-panels-at-the-virtual-sitc-2020-immuno-oncology-event-hosted-by-b-riley\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agenus-and-dr-steven-oday-to-participate-in-panels-at-the-virtual-sitc-2020-immuno-oncology-event-hosted-by-b-riley\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NDc0OCMzODIzNjY2IzIwMjAwNDA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NDc0OCMzODIzNjY2IzIwMjAwNDA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agenus-and-dr-steven-oday-to-participate-in-panels-at-the-virtual-sitc-2020-immuno-oncology-event-hosted-by-b-riley\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Agenus and Dr. Steven O\u2019Day to Participate in Panels at the Virtual SITC 2020 Immuno-Oncology Event Hosted by B. Riley\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Agenus and Dr. Steven O\u2019Day to Participate in Panels at the Virtual SITC 2020 Immuno-Oncology Event Hosted by B. Riley - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/agenus-and-dr-steven-oday-to-participate-in-panels-at-the-virtual-sitc-2020-immuno-oncology-event-hosted-by-b-riley\/","og_locale":"en_US","og_type":"article","og_title":"Agenus and Dr. Steven O\u2019Day to Participate in Panels at the Virtual SITC 2020 Immuno-Oncology Event Hosted by B. Riley - Market Newsdesk","og_description":"LEXINGTON, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) — Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced that Dr. Steven O\u2019Day, Executive Director of the John Wayne Cancer Institute, Dr. Jennifer Buell, President and COO of Agenus, and Patrick Jordan, COO of AgenTus Therapeutics, will participate in panel discussions at the Virtual SITC 2020 Immuno-Oncology Event hosted by B. Riley. Date: Thursday, November 12, 2020 Panel #2: Next-Gen Checkpoint Inhibitors (CPI) and Co-Stimulatory Agonists Finally Ready for Prime Time Time: 1:00 PM \u2013 2:00 PM ETConference ID: 311564 Agenus Inc.Steven O\u2019Day, MD \u2013 Executive Director of the John Wayne … Continue reading \"Agenus and Dr. Steven O\u2019Day to Participate in Panels at the Virtual SITC 2020 Immuno-Oncology Event Hosted by B. Riley\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/agenus-and-dr-steven-oday-to-participate-in-panels-at-the-virtual-sitc-2020-immuno-oncology-event-hosted-by-b-riley\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-12T14:03:33+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NDc0OCMzODIzNjY2IzIwMjAwNDA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agenus-and-dr-steven-oday-to-participate-in-panels-at-the-virtual-sitc-2020-immuno-oncology-event-hosted-by-b-riley\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agenus-and-dr-steven-oday-to-participate-in-panels-at-the-virtual-sitc-2020-immuno-oncology-event-hosted-by-b-riley\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Agenus and Dr. Steven O\u2019Day to Participate in Panels at the Virtual SITC 2020 Immuno-Oncology Event Hosted by B. Riley","datePublished":"2020-11-12T14:03:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agenus-and-dr-steven-oday-to-participate-in-panels-at-the-virtual-sitc-2020-immuno-oncology-event-hosted-by-b-riley\/"},"wordCount":505,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agenus-and-dr-steven-oday-to-participate-in-panels-at-the-virtual-sitc-2020-immuno-oncology-event-hosted-by-b-riley\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NDc0OCMzODIzNjY2IzIwMjAwNDA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agenus-and-dr-steven-oday-to-participate-in-panels-at-the-virtual-sitc-2020-immuno-oncology-event-hosted-by-b-riley\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/agenus-and-dr-steven-oday-to-participate-in-panels-at-the-virtual-sitc-2020-immuno-oncology-event-hosted-by-b-riley\/","name":"Agenus and Dr. Steven O\u2019Day to Participate in Panels at the Virtual SITC 2020 Immuno-Oncology Event Hosted by B. Riley - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agenus-and-dr-steven-oday-to-participate-in-panels-at-the-virtual-sitc-2020-immuno-oncology-event-hosted-by-b-riley\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agenus-and-dr-steven-oday-to-participate-in-panels-at-the-virtual-sitc-2020-immuno-oncology-event-hosted-by-b-riley\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NDc0OCMzODIzNjY2IzIwMjAwNDA=","datePublished":"2020-11-12T14:03:33+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agenus-and-dr-steven-oday-to-participate-in-panels-at-the-virtual-sitc-2020-immuno-oncology-event-hosted-by-b-riley\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/agenus-and-dr-steven-oday-to-participate-in-panels-at-the-virtual-sitc-2020-immuno-oncology-event-hosted-by-b-riley\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agenus-and-dr-steven-oday-to-participate-in-panels-at-the-virtual-sitc-2020-immuno-oncology-event-hosted-by-b-riley\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NDc0OCMzODIzNjY2IzIwMjAwNDA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NDc0OCMzODIzNjY2IzIwMjAwNDA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agenus-and-dr-steven-oday-to-participate-in-panels-at-the-virtual-sitc-2020-immuno-oncology-event-hosted-by-b-riley\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Agenus and Dr. Steven O\u2019Day to Participate in Panels at the Virtual SITC 2020 Immuno-Oncology Event Hosted by B. Riley"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/379803","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=379803"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/379803\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=379803"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=379803"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=379803"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}